Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Moyle

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Chemical Science|June 19, 2018
Double conjugation strategy to incorporate lipid adjuvants into multiantigenic vaccinesWaleed M Hussein, Tzu-Yu Liu, Pirashanthini Maruthayanar, et al.
Discovery Medicine|January 1, 2015
The contribution of non-human primate models to the development of human vaccinesTania Rivera-Hernandez, Diane G Carnathan, Peter M Moyle, et al.
The Science of the Total Environment|July 27, 2019
Soil bacterial diffusible and volatile organic compounds inhibit Phytophthora capsici and promote plant growthSharifah Farhana Syed-Ab-Rahman, Lilia C Carvalhais, Elvis T Chua, et al.
Nanomedicine (London, England)|December 23, 2014
Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicityMehfuz Zaman, Saranya Chandrudu, Ashwini K Giddam, et al.
Journal of Medicinal Chemistry|December 13, 2007
Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidatesAbu-Baker M Abdel-Aal, Michael R Batzloff, Yoshio Fujita, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2015
Combined synthetic and recombinant techniques for the development of lipoprotein-based, self-adjuvanting vaccines targeting human papillomavirus type-16 associated tumorsPeter M Moyle, Wei Dai, Tzu-Yu Liu, et al.
Journal of Medicinal Chemistry|February 19, 2008
Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccinesPavla Simerska, Abu-Baker M Abdel-Aal, Yoshio Fujita, et al.
Nanotechnology|July 12, 2019
Peptide-based targeted polymeric nanoparticles for siRNA deliveryWaleed M Hussein, Yee S Cheong, Chang Liu, et al.
Mbio|May 2, 2019
An Experimental Group A <i>Streptococcus</i> Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate ModelTania Rivera-Hernandez, Diane G Carnathan, Scott Jones, et al.
Nanomedicine (London, England)|April 25, 2013
Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccineAbdullah A H Ahmad Fuaad, Zhongfan Jia, Mehfuz Zaman, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Chemical Science|June 19, 2018
Double conjugation strategy to incorporate lipid adjuvants into multiantigenic vaccinesWaleed M Hussein, Tzu-Yu Liu, Pirashanthini Maruthayanar, et al.
Discovery Medicine|January 1, 2015
The contribution of non-human primate models to the development of human vaccinesTania Rivera-Hernandez, Diane G Carnathan, Peter M Moyle, et al.
The Science of the Total Environment|July 27, 2019
Soil bacterial diffusible and volatile organic compounds inhibit Phytophthora capsici and promote plant growthSharifah Farhana Syed-Ab-Rahman, Lilia C Carvalhais, Elvis T Chua, et al.
Nanomedicine (London, England)|December 23, 2014
Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicityMehfuz Zaman, Saranya Chandrudu, Ashwini K Giddam, et al.
Journal of Medicinal Chemistry|December 13, 2007
Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidatesAbu-Baker M Abdel-Aal, Michael R Batzloff, Yoshio Fujita, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2015
Combined synthetic and recombinant techniques for the development of lipoprotein-based, self-adjuvanting vaccines targeting human papillomavirus type-16 associated tumorsPeter M Moyle, Wei Dai, Tzu-Yu Liu, et al.
Journal of Medicinal Chemistry|February 19, 2008
Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccinesPavla Simerska, Abu-Baker M Abdel-Aal, Yoshio Fujita, et al.
Nanotechnology|July 12, 2019
Peptide-based targeted polymeric nanoparticles for siRNA deliveryWaleed M Hussein, Yee S Cheong, Chang Liu, et al.
Mbio|May 2, 2019
An Experimental Group A <i>Streptococcus</i> Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate ModelTania Rivera-Hernandez, Diane G Carnathan, Scott Jones, et al.
Nanomedicine (London, England)|April 25, 2013
Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccineAbdullah A H Ahmad Fuaad, Zhongfan Jia, Mehfuz Zaman, et al.
Pageof 5